or
forgot password
  • cancer clinical trials in texas

  • Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor
    Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
    Mary Crowley Medical Research Center at Sammons Cancer Center

    Trial Locations
    Mary Crowley Medical Research Center at Sammons Cancer Center
    Tyler Cancer Center
    Lung Cancer
    Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
    M. D. Anderson Cancer Center at University of Texas

    Trial Locations
    M. D. Anderson Cancer Center at University of Texas
    Joe Arrington Cancer Research and Treatment Center
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    The Don and Sybil Harrington Cancer Center

    Trial Locations
    The Don and Sybil Harrington Cancer Center
    University Medical Center Brackenridge
    University of Texas Southwestern Medical Center
    Brooke Army Medical Center
    University of Texas Medical Branch
    Methodist Hospital
    M D Anderson Cancer Center
    Lyndon Baines Johnson General Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers.
    MD Anderson Cancer Center/University of Texas
    Houston, Texas 77030
    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome, Systemic Mastocytosis
    Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Brain and Central Nervous System Tumors
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Baylor University Medical Center - Houston

    Trial Locations
    Baylor University Medical Center - Houston
    M. D. Anderson Cancer Center at University of Texas
    Methodist Hospital
    Multiple Myeloma and Plasma Cell Neoplasm
    131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
    Mary Crowley Medical Research Center
    Dallas, Texas 75246
    Malignant Glioma, Glioblastoma Multiforme, GBM, Anaplastic Astrocytoma, Oligo-Astrocytoma, Gliosarcoma
    Scleroderma: Cyclophosphamide or Transplantation (SCOT)
    MD Anderson Cancer Center

    Trial Locations
    MD Anderson Cancer Center
    University of Texas-Houston Medical School
    Scleroderma, Systemic, Sclerosis, Autoimmune Disease
    Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Melanoma (Skin)
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Ut Southwestern Medical Center

    Trial Locations
    Ut Southwestern Medical Center
    The University of Texas MD Anderson Cancer Center
    Myeloid Leukemia, Chronic, Chronic-Phase
    Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
    University of Texas Health Science Center
    San Antonio, Texas 78284
    Chronic Lymphoproliferative Diseases
    Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin
    Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sirolimus in Treating Patients With Angiomyolipoma of the Kidney
    University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas 75235-8897
    Nonmalignant Neoplasm
    Vaccine Therapy in Treating Patients With Malignant Melanoma
    Simmons Cancer Center at University of Texas Southwestern Medical Center at Dallas

    Trial Locations
    Simmons Cancer Center at University of Texas Southwestern Medical Center at Dallas
    M.D. Anderson Cancer Center at University of Texas
    Melanoma (Skin)
    Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
    M. D. Anderson Cancer Center at University of Texas

    Trial Locations
    M. D. Anderson Cancer Center at University of Texas
    University of Texas Health Science Center at San Antonio
    Scott and White Cancer Institute
    Liver Cancer
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA South Texas Health Care System, San Antonio
    San Antonio, Texas 78229
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Texas Tech University Health Science Center-Amarillo

    Trial Locations
    Texas Tech University Health Science Center-Amarillo
    Driscoll Children's Hospital
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    Cook Children's Medical Center
    Baylor College of Medicine
    M D Anderson Cancer Center
    University of Texas Health Science Center at San Antonio
    Methodist Children's Hospital of South Texas
    Scott and White Memorial Hospital
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Veterans Affairs Medical Center - Dallas
    Brooke Army Medical Center
    Veterans Affairs Medical Center - Houston
    Baylor University Medical Center - Houston
    Ben Taub General Hospital
    Methodist Hospital
    St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital
    Wilford Hall Medical Center
    UMC Southwest Cancer and Research Center
    University of Texas Health Science Center at San Antonio
    Metastatic Cancer, Prostate Cancer